Loi S - Search Results

1

Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape.

Bidwell BN, Slaney CY, Withana NP, Forster S, Cao Y, Loi S, Andrews D, Mikeska T, Mangan NE, Samarajiwa SA, de Weerd NA, Gould J, Argani P, Möller A, Smyth MJ, Anderson RL, Hertzog PJ, Parker BS. Bidwell BN, et al. Among authors: loi s. Nat Med. 2012 Aug;18(8):1224-31. doi: 10.1038/nm.2830. Epub 2012 Jul 22. Nat Med. 2012. PMID: 22820642

2

Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context.

Abraham G, Kowalczyk A, Loi S, Haviv I, Zobel J. Abraham G, et al. Among authors: loi s. BMC Bioinformatics. 2010 May 25;11:277. doi: 10.1186/1471-2105-11-277. BMC Bioinformatics. 2010. PMID: 20500821 Free PMC article.

3

Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy.

Stagg J, Loi S, Divisekera U, Ngiow SF, Duret H, Yagita H, Teng MW, Smyth MJ. Stagg J, et al. Among authors: loi s. Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7142-7. doi: 10.1073/pnas.1016569108. Epub 2011 Apr 11. Proc Natl Acad Sci U S A. 2011. PMID: 21482773 Free PMC article.

4

Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors.

Mattarollo SR, Loi S, Duret H, Ma Y, Zitvogel L, Smyth MJ. Mattarollo SR, et al. Among authors: loi s. Cancer Res. 2011 Jul 15;71(14):4809-20. doi: 10.1158/0008-5472.CAN-11-0753. Epub 2011 Jun 6. Cancer Res. 2011. PMID: 21646474

5

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer.

Loi S, Pommey S, Haibe-Kains B, Beavis PA, Darcy PK, Smyth MJ, Stagg J. Loi S, et al. Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11091-6. doi: 10.1073/pnas.1222251110. Epub 2013 Jun 17. Proc Natl Acad Sci U S A. 2013. PMID: 23776241 Free PMC article.

6

Biology of breast cancer during pregnancy using genomic profiling.

Azim HA Jr, Brohée S, Peccatori FA, Desmedt C, Loi S, Lambrechts D, Dell'Orto P, Majjaj S, Jose V, Rotmensz N, Ignatiadis M, Pruneri G, Piccart M, Viale G, Sotiriou C. Azim HA Jr, et al. Among authors: loi s. Endocr Relat Cancer. 2014 Aug;21(4):545-54. doi: 10.1530/ERC-14-0111. Epub 2014 May 13. Endocr Relat Cancer. 2014. PMID: 24825746

7

Oncogene addiction and immunity: clinical implications of tumour infiltrating lymphocytes in breast cancers overexpressing the HER2/neu oncogene.

Savas P, Caramia F, Teo ZL, Loi S. Savas P, et al. Among authors: loi s. Curr Opin Oncol. 2014 Nov;26(6):562-7. doi: 10.1097/CCO.0000000000000131. Curr Opin Oncol. 2014. PMID: 25188474 Review.

8

Precision medicine for metastatic breast cancer--limitations and solutions.

Arnedos M, Vicier C, Loi S, Lefebvre C, Michiels S, Bonnefoi H, Andre F. Arnedos M, et al. Among authors: loi s. Nat Rev Clin Oncol. 2015 Dec;12(12):693-704. doi: 10.1038/nrclinonc.2015.123. Epub 2015 Jul 21. Nat Rev Clin Oncol. 2015. PMID: 26196250 Review.

9

Relevance of tumor-infiltrating lymphocytes in breast cancer.

Dushyanthen S, Beavis PA, Savas P, Teo ZL, Zhou C, Mansour M, Darcy PK, Loi S. Dushyanthen S, et al. Among authors: loi s. BMC Med. 2015 Aug 24;13:202. doi: 10.1186/s12916-015-0431-3. BMC Med. 2015. PMID: 26300242 Free PMC article. Review.

10

CD73: A potential biomarker for anti-PD-1 therapy.

Beavis PA, Slaney CY, Milenkovski N, Henderson MA, Loi S, Stagg J, Kershaw MH, Darcy PK. Beavis PA, et al. Among authors: loi s. Oncoimmunology. 2015 May 5;4(11):e1046675. doi: 10.1080/2162402X.2015.1046675. eCollection 2015 Nov. Oncoimmunology. 2015. PMID: 26451321 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

495 results

Search Page